• 2025 update on clinical trials in immune thrombocytopenia
• A Case Report of Crotalidae Immune F(ab')(2)-associated Coagulopathy Recurrence in a Preschool-age Child
• A case report of hemophagocytic lymphohistiocytosis induced by toripalimab plus chemoradiotherapy in cervical cancer
• A Phase 1b PK/PD Study to Demonstrate Antigen Elimination With RLYB212, a Monoclonal Anti-HPA-1a Antibody for FNAIT Prevention
• A Rare Case of Immune Thrombocytopenia With Intracranial Hemorrhage Secondary to Cavernous Malformation
• Activation of the HMGB1-TLR4 pathway impacts the functionality of bone marrow mesenchymal stem cells and disrupts macrophage polarization in immune thrombocytopenia
• Acute lower-extremity arterial thrombosis with immune thrombocytopenia
• ADAMTS13 in the New Era of TTP
• Adequate IVIG dosing is associated with an improved long-term outcome in secondary immunodeficiency: A prospective, non-interventional study
• Age, gender, and infectious status-wise assessments of hematological parameters among patients with dengue infection
• All-trans retinoic acid in hematologic disorders: not just acute promyelocytic leukemia
• Alternative Dosing of Eltrombopag for the Treatment of Chronic, Steroid-Refractory Immune Thrombocytopenia
• An Investigation of Mortality Associated With Comorbid Pneumonia and Thrombocytopenia in a Rural Southwest Missouri Hospital System
• Analysis of genetic etiology of 234 deaths in the pediatric intensive care unit with suspected genetic diseases
• Anti-CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
• Anti-PF4 positivity and platelet activation after Ad26.COV2·S vaccination in Brazil
• Anti-platelet factor 4 immunothrombotic syndromes
• Association of depression and social anxiety symptom scores with disease characteristics in pediatric patients with chronic immune thrombocytopenia: a cross-sectional study
• Association of Metal Cations with the Anti-PF4/Heparin Antibody Response in Heparin-Induced Thrombocytopenia
• Avatrombopag for severe refractory thrombocytopenia in a pediatric patient with ALL following allogeneic hematopoietic stem cell transplantation: A case report
• Biologic therapy for ulcerative colitis associated with immune thrombocytopenia
• Budd-Chiari Syndrome Associated With Autoimmune Hemolytic Anemia, Immune Thrombocytopenic Purpura, and Lupus Nephritis: A Case Report
• Case report: Management of pregnancy-associated immune thrombocytopenia in a French bulldog with dystocia
• Ceftaroline-Induced Thrombocytopenia: A Case Report
• Clinical characteristics, effectiveness and cost of different treatment methods for invasive <em>Klebsiella pneumonia</em>e liver abscess syndrome
• Clinical presentation, outcome and prognostic factors in dogs with immune-mediated haemolytic anaemia: a retrospective single-centre study of 104 cases in Ireland (2002-2020)
• Clinical trial landscape for immune thrombocytopenia: Progress and the long road ahead
• Comparative analysis of adverse events associated with CDK4/6 inhibitors based on FDA's adverse event reporting system: a case control pharmacovigilance study
• Correction to: SARS-CoV-2 infection-induced immune thrombocytopenia: a systematic review of current reports
• Could machine learning revolutionize how we treat immune thrombocytopenia?
• Current insights into human pathogenic phenuiviruses and the host immune system
• Deciphering the evolutionary landscape of severe fever with thrombocytopenia syndrome virus across East Asia
• Diagnosis and Treatment Challenges of <em>Candida guilliermondii</em> in Immunocompromised Patients: A Case Study in a Neutropenic AML Patient
• Diagnostic and Therapeutic Strategies in Evans Syndrome: A Case Report and Literature Review
• Differential detection of megakaryocytic and erythroid DNA in plasma in hematological disorders
• Differential diagnosis and therapy of immune thrombocytopenia
• Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus: data from the Spanish society of rheumathology Lupus Register (RELESSER)
• Double-territory STEMI with cardiogenic shock in immune thrombocytopenic purpura with severe thrombocytopenia-a case report
• Effective and safe use of intramuscular clozapine in a patient presenting with catatonia and thrombocytopenia
• Effectiveness and safety of anlotinib plus anti-programmed cell death 1/ligand 1 (anti-PD-1/PD-L1) antibodies as maintenance therapy after first-line chemotherapy combined with anti-PD-1/PD-L1 antibodies in extensive-stage small cell lung cancer: a real-w
• Efficacy and safety of camrelizumab, apatinib, and capecitabine combination therapy in advanced biliary tract cancer: a phase 2, nonrandomized, prospective study
• Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk
• Efficacy and Safety of Re-Challenging PD-1 Inhibitors in Second-Line Treatment in Metastatic Nasopharyngeal Carcinoma Previously Treated with Chemotherapy and PD-1 Inhibitors
• Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial
• Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial - Authors' reply
• Erratum: Causal relationship between gut microbiota and immune thrombocytopenia: a Mendelian randomization study of two samples
• Evans syndrome: Disease awareness and clinical management in a nation-wide ITP-NET survey
• Extremely Rare Case of Successful Treatment of Foot Ulcer Associated with Evans' Syndrome and Buerger's Disease
• Familial autoimmunity and risk of developing immune thrombocytopenia and Evans syndrome
• First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors
• Flow cytometry vs conventional methods for the evaluation of anti-PF4/heparin antibodies: a single center study
• Fostamatinib for immune thrombocytopenic purpura in adult patients: A systematic review and meta-analysis
• Haploinsufficiency in PTPN2 leads to early-onset systemic autoimmunity from Evans syndrome to lupus
• Helicobacter pylori-Associated Immune Thrombocytopenia: Diagnostic and Therapeutic Approach
• Hematologic Emergencies: Recognition and Initial Management
• Idiopathic Thrombocytopenic Purpura (ITP) Complicated by a Hemorrhagic Ovarian Cyst and Hemoperitoneum: A Case Report
• Immune thrombocytopenia and pregnancy: challenges and opportunities in diagnosis and management
• Immune thrombocytopenia increases the risk of thrombosis: A two-sample Mendelian randomization study
• Immune-mediated thrombotic thrombocytopenic purpura with ischaemic cerebral infarction preceding onset of thrombocytopenia and microangiopathic haemolytic anaemia: A case report
• Immuno-Haematologic Aspects of Dengue Infection: Biologic Insights and Clinical Implications
• Immunoglobulins: Mechanistic Approaches in Moderation of Various Inflammatory and Anti-Inflammatory Pathways
• Impact of pre-delivery medication treatment on delivery outcome in patients with primary immune thrombocytopenia: a cohort study
• Increased risk of haematological malignancy in adults over age 60 with thrombocytopenia compared with matched controls: Time for an upfront bone marrow evaluation?
• Influence of short-term refrigeration on collagen-dependent signalling mechanisms in stored platelets
• Inpatient outcomes of NSTEMI among patients with immune thrombocytopenia: a propensity matched national study
• Interleukin (IL)-1B and IL-1 receptor antagonist gene polymorphisms in children with primary immune thrombocytopenia
• Long-term complete remissions of refractory severe idiopathic immune thrombocytopenia treated with daratumumab: A case series
• Maturing neutrophils of lower density associate with thrombocytopenia in Puumala orthohantavirus-caused hemorrhagic fever with renal syndrome
• N-glycosylation of viral glycoprotein is a novel determinant for the tropism and virulence of highly pathogenic tick-borne bunyaviruses
• Navigating the conundrum of co-existing autoantibodies and alloantibodies in a case of Evans syndrome
• Novel treatments for immune thrombocytopenia: targeting platelet autoantibodies
• Perinatal outcomes in pregnant women with ITP: a single tertiary center experience
• Plasma concentration of thrombopoietin in dogs with immune thrombocytopenia
• Platelet response to romiplostim amongst patients with newly diagnosed, persistent, and chronic immune thrombocytopenia in routine clinical practice in Denmark, Sweden, and Norway
• Possible immune mechanisms of gut microbiota and its metabolites in the occurrence and development of immune thrombocytopenia
• Post-marketing safety surveillance of fostamatinib: an observational, pharmacovigilance study leveraging FAERS database
• Primary Sjögren's syndrome without ocular manifestation: a case report
• Prognostic Factors for Chronic Thrombocytopenia in Systemic Lupus Erythematosus with Immune Thrombocytopenia
• Quality of life in childhood immune thrombocytopenia: Revision of the Kids' ITP Tools (KIT)
• Real-world clinical outcomes with fostamatinib for the treatment of refractory chronic immune thrombocytopenia: a single-center experience
• Relationship between response to first-line steroid treatment in adult immune thrombocytopenic purpura and the course of the disease
• Retrospective Evaluation of Survival and Prognostic Factors in Immune Thrombocytopenia: A Single-Center and Cross-Sectional Study
• Retrospective evaluation of the short-term response of human intravenous immunoglobulin therapy in the management of canine immune-mediated thrombocytopenia (2010-2015): 27 cases
• Romiplostim for treatment of thrombocytopenia in dogs: A retrospective assessment and clinical outcomes
• Romiplostim in chemotherapy-induced thrombocytopenia: A review of the literature
• Romiplostim use in immune thrombocytopenia: Experience in Cuenca, Ecuador
• Secondary Evans Syndrome Presenting With Lupus Anticoagulant
• Severe Thrombocytopenia Secondary to Systemic Lupus Erythematosus With Antiphospholipid Antibodies in a Middle-Aged Woman
• Sodium-Dependent Multivitamin Transporter Deficiency
• Spontaneous Peritoneal Hemorrhage and Anemia: A Rare Case Report of Immune Thrombocytopenic Purpura
• Tapering and Sustained Remission of Thrombopoietin Receptor Agonists (TPO-RAs): Is it Time for Paediatric ITP?
• The Diverse Roles of ETV6 Alterations in B-Lymphoblastic Leukemia and Other Hematopoietic Cancers
• The immun function of dendritic cells in SFTS patients
• The immune thrombocytopenia paradox: Should we be concerned about thrombosis in ITP?
• The N and C-terminal deleted variant of the dengue virus NS1 protein is a potential candidate for dengue vaccine development
• Thoracic endovascular aortic repair with unibody single-branched stent-graft for type B aortic dissection: A real-world multicenter study
• Thrombocytopenia following iron repletion with ferrous gluconate
• Treatment of Immune Thrombocytopenia: Contextualization from a Historical Perspective
• Uso de romiplostim en trombocitopenia inmunitaria: experiencia en Cuenca (Ecuador)
• What's in a name: defining pediatric refractory ITP